| Long-Term Effects of COVID-19 | Lifetime | 63 | IT 13 | 99.11 |
| Dementia and Cognitive Impairment Research | Lifetime | 175 | IT 2 | 99.41 |
| Alzheimer's disease research and treatments | Lifetime | 241 | IT 3 | 99.36 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 247 | IT 17 | 99.12 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 149 | IT 7 | 98.39 |
| COVID-19 Clinical Research Studies | Lifetime | 870 | IT 101 | 97.10 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 195 | IT 17 | 97.66 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 527 | IT 44 | 97.81 |
| Cerebrovascular and genetic disorders | Lifetime | 63 | IT 3 | 97.26 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 387 | IT 7 | 96.90 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 988 | IT 32 | 96.47 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 558 | IT 11 | 96.02 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 668 | IT 70 | 95.35 |
| Migraine and Headache Studies | Lifetime | 673 | IT 107 | 93.53 |
| Neurological diseases and metabolism | Lifetime | 702 | IT 47 | 92.61 |
| Neurological Complications and Syndromes | Lifetime | 955 | IT 55 | 87.71 |
| Spatial Neglect and Hemispheric Dysfunction | Lifetime | 895 | IT 125 | 81.45 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 150 | IT 1 | 98.48 |
| Long-Term Effects of COVID-19 | 2021-2025 | 280 | IT 47 | 96.95 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 200 | IT 19 | 97.32 |
| Alzheimer's disease research and treatments | 2021-2025 | 231 | IT 3 | 97.40 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 227 | IT 23 | 95.81 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 388 | IT 36 | 93.82 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 169 | IT 5 | 93.96 |
| Neurosurgical Procedures and Complications | 2021-2025 | 162 | IT 4 | 92.08 |
| Acute Ischemic Stroke Management | 2021-2025 | 854 | IT 28 | 94.16 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 270 | IT 42 | 90.05 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 563 | IT 3 | 79.56 |
| Migraine and Headache Studies | 2021-2025 | 880 | IT 137 | 75.17 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 657 | IT 27 | 70.81 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 297 | IT 23 | 66.92 |
| S100 Proteins and Annexins | 2021-2025 | 766 | IT 47 | 63.72 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 922 | IT 140 | 56.83 |
| Restless Legs Syndrome Research | 2021-2025 | 827 | IT 105 | 45.30 |
